1. Home
  2. TRML
  3. TRML News

Latest Tourmaline Bio Inc. (TRML) News on September 16, 2025

Tourmaline Bio (TRML): Assessing Valuation as Market Interest Grows
TRML

Simply Wall St.

2 days ago

Tourmaline Bio (TRML): Assessing Valuation as Market Interest Grows

Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'
TRML

Investor's Business Daily

6 days ago

Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'

TRML

MT Newswires

6 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

TRML

MT Newswires

6 days ago

Sector Update: Health Care

TRML

MT Newswires

6 days ago

Top Midday Gainers

Novartis & Tourmaline, Anglo American & Teck, CoreWeave AI fund
TRML

Yahoo Finance Video

6 days ago

Novartis & Tourmaline, Anglo American & Teck, CoreWeave AI fund

TRML

MT Newswires

7 days ago

Tourmaline Bio Agrees to $1.4 Billion Takeover by Novartis

Novartis Agrees to Buy Tourmaline Bio in $1.4 Billion-Dollar Deal
TRML

The Wall Street Journal

7 days ago

Novartis Agrees to Buy Tourmaline Bio in $1.4 Billion-Dollar Deal

Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
TRML

GlobeNewswire

7 days ago

Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
TRML

GlobeNewswire

7 days ago

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)

H.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 Results
TRML

Insider Monkey

4 months ago

H.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 Results

Tourmaline Bio Announces Positive Topline Results from the Ongoing Phase 2 TRANQUILITY Trial Evaluating Pacibekitug in Patients with Elevated High-Sensitivity C-reactive Protein and Chronic Kidney Disease
TRML

GlobeNewswire

4 months ago

Tourmaline Bio Announces Positive Topline Results from the Ongoing Phase 2 TRANQUILITY Trial Evaluating Pacibekitug in Patients with Elevated High-Sensitivity C-reactive Protein and Chronic Kidney Disease

Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
TRML

GlobeNewswire

4 months ago

Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025

Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
TRML

GlobeNewswire

4 months ago

Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights

Here's Why We're Not Too Worried About Tourmaline Bio's (NASDAQ:TRML) Cash Burn Situation
TRML

Simply Wall St.

5 months ago

Here's Why We're Not Too Worried About Tourmaline Bio's (NASDAQ:TRML) Cash Burn Situation

Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
TRML

GlobeNewswire

6 months ago

Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls
TRML

TipRanks

6 months ago

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls

Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025
TRML

GlobeNewswire

6 months ago

Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025

Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference
TRML

GlobeNewswire

8 months ago

Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference

Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
TRML

GlobeNewswire

8 months ago

Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
TRML

GlobeNewswire

9 months ago

Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
TRML

GlobeNewswire

10 months ago

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

Tourmaline Bio, Inc. Reports Third Quarter Financial Results
TRML

TipRanks

10 months ago

Tourmaline Bio, Inc. Reports Third Quarter Financial Results

Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
TRML

GlobeNewswire

10 months ago

Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Tourmaline Bio to Present at Upcoming Investor Conferences
TRML

GlobeNewswire

a year ago

Tourmaline Bio to Present at Upcoming Investor Conferences

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
TRML

GlobeNewswire

a year ago

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
TRML

GlobeNewswire

a year ago

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
TRML

GlobeNewswire

a year ago

Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board

Tourmaline Bio to Present at Upcoming Investor Conferences
TRML

GlobeNewswire

a year ago

Tourmaline Bio to Present at Upcoming Investor Conferences

Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock
TRML

Simply Wall St.

a year ago

Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
TRML

GlobeNewswire

a year ago

Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
TRML

GlobeNewswire

a year ago

Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024

Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
TRML

GlobeNewswire

a year ago

Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer

Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
TRML

GlobeNewswire

a year ago

Tourmaline Bio to Present at the Jefferies Global Healthcare Conference

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
TRML

GlobeNewswire

a year ago

Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial

Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
TRML

GlobeNewswire

a year ago

Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
TRML

GlobeNewswire

a year ago

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
TRML

GlobeNewswire

a year ago

Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock
TRML

Simply Wall St.

2 years ago

Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock

Tourmaline Bio to Present at Upcoming Investor Conferences
TRML

GlobeNewswire

2 years ago

Tourmaline Bio to Present at Upcoming Investor Conferences

Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
TRML

GlobeNewswire

2 years ago

Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
TRML

GlobeNewswire

2 years ago

Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

WisdomTree, Inc. (WT) Earnings Expected to Grow: Should You Buy?
TRML

Zacks

2 years ago

WisdomTree, Inc. (WT) Earnings Expected to Grow: Should You Buy?

Viasat (VSAT) Elevates In-Flight Experience for Lufthansa
TRML

Zacks

2 years ago

Viasat (VSAT) Elevates In-Flight Experience for Lufthansa

Tourmaline Bio Announces Pricing of Public Offering of Common Stock
TRML

GlobeNewswire

2 years ago

Tourmaline Bio Announces Pricing of Public Offering of Common Stock

Tourmaline Bio Announces Proposed Public Offering of Common Stock
TRML

GlobeNewswire

2 years ago

Tourmaline Bio Announces Proposed Public Offering of Common Stock

New York Community Bancorp (NYCB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
TRML

Zacks

2 years ago

New York Community Bancorp (NYCB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Lufthansa Group Selects Viasat for In-Flight Connectivity Upgrades
TRML

PR Newswire

2 years ago

Lufthansa Group Selects Viasat for In-Flight Connectivity Upgrades

MAG Announces Fourth Quarter and 2023 Production From Juanicipio
TRML

GlobeNewswire

2 years ago

MAG Announces Fourth Quarter and 2023 Production From Juanicipio

13 Most Buzzing Stocks To Buy Now
TRML

Insider Monkey

2 years ago

13 Most Buzzing Stocks To Buy Now

Recurrent Energy Announces $500 Million Capital Commitment from BlackRock to Grow Its Global Renewable Energy Platform
TRML

PR Newswire

2 years ago

Recurrent Energy Announces $500 Million Capital Commitment from BlackRock to Grow Its Global Renewable Energy Platform

TRML

Business Wire

2 years ago

FCPT Announces Tax Treatment of 2023 Distributions

TRML

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Synovus Financial Corp Earnings Call

Bank OZK Announces Record Fourth Quarter and Full Year 2023 Earnings
TRML

GlobeNewswire

2 years ago

Bank OZK Announces Record Fourth Quarter and Full Year 2023 Earnings

Synovus (SNV) Stock Dips 1% as Q4 Earnings Miss Estimates
TRML

Zacks

2 years ago

Synovus (SNV) Stock Dips 1% as Q4 Earnings Miss Estimates

Sales And Marketing Software Stocks Q3 Highlights: Sprinklr (NYSE:CXM)
TRML

StockStory

2 years ago

Sales And Marketing Software Stocks Q3 Highlights: Sprinklr (NYSE:CXM)

Five Key Charts to Watch in Global Commodities This Week
TRML

Bloomberg

2 years ago

Five Key Charts to Watch in Global Commodities This Week

Insider Suneel Gupta Sells 5,000 Shares of Protagonist Therapeutics Inc (PTGX)
TRML

GuruFocus.com

2 years ago

Insider Suneel Gupta Sells 5,000 Shares of Protagonist Therapeutics Inc (PTGX)

Hain Celestial launches better-for-you offering in $9B tortilla chip category
TRML

Food Dive

2 years ago

Hain Celestial launches better-for-you offering in $9B tortilla chip category

TRML

Business Wire

2 years ago

FCPT to Report Fourth Quarter 2023 Financial Results

Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)
TRML

GlobeNewswire

2 years ago

Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)

TRML

Business Wire

2 years ago

FCPT Announces Acquisition of Two Oak Street Health Properties for $4.2 Million

5 Great REITs To Buy In 2024
TRML

Benzinga

2 years ago

5 Great REITs To Buy In 2024

enCore Energy Provides Q4/23 ATM Quarterly Sales Update
TRML

CNW Group

2 years ago

enCore Energy Provides Q4/23 ATM Quarterly Sales Update

Heritage Financial Announces Earnings Release Date and Conference Call
TRML

PR Newswire

2 years ago

Heritage Financial Announces Earnings Release Date and Conference Call

Kelly Completes Sale of European Staffing Business to Gi Group Holdings S.P.A.
TRML

GlobeNewswire

2 years ago

Kelly Completes Sale of European Staffing Business to Gi Group Holdings S.P.A.

Bumble Stock (NASDAQ:BMBL): Options Traders are Still Swiping Right
TRML

TipRanks

2 years ago

Bumble Stock (NASDAQ:BMBL): Options Traders are Still Swiping Right

ABM Industries Inc's Dividend Analysis
TRML

GuruFocus.com

2 years ago

ABM Industries Inc's Dividend Analysis

TRML

Business Wire

2 years ago

FCPT Announces Sale-Leaseback of a Tire Discounters Property for $1.8 Million

25 Best Campsites in the US
TRML

Insider Monkey

2 years ago

25 Best Campsites in the US

TRML

Business Wire

2 years ago

FCPT Announces Acquisition of Two Popeyes Properties for $4.7 Million

TRML

Business Wire

2 years ago

FCPT Announces Sale-Leaseback of a Tire Discounters Property for $1.7 Million

New York Mortgage Trust Inc's Dividend Analysis
TRML

GuruFocus.com

2 years ago

New York Mortgage Trust Inc's Dividend Analysis

Tourmaline Bio added to the NASDAQ Biotechnology Index
TRML

GlobeNewswire

2 years ago

Tourmaline Bio added to the NASDAQ Biotechnology Index

Xometry and Lazydays Holdings have been highlighted as Zacks Bull and Bear of the Day
TRML

Zacks

2 years ago

Xometry and Lazydays Holdings have been highlighted as Zacks Bull and Bear of the Day

Kyivstar restores voice services across Ukraine, starts the reactivation of mobile data services
TRML

GlobeNewswire

2 years ago

Kyivstar restores voice services across Ukraine, starts the reactivation of mobile data services

Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
TRML

GlobeNewswire

2 years ago

Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board

3 Niche Stocks on the Rise: Why OC, LYB, and UAN Are Must-Buys
TRML

InvestorPlace

2 years ago

3 Niche Stocks on the Rise: Why OC, LYB, and UAN Are Must-Buys

Timken (NYSE:TKR) Shareholders Will Want The ROCE Trajectory To Continue
TRML

Simply Wall St.

2 years ago

Timken (NYSE:TKR) Shareholders Will Want The ROCE Trajectory To Continue

CTO Realty (CTO) Sells Assets, Ups Financial Strength, Stock Up
TRML

Zacks

2 years ago

CTO Realty (CTO) Sells Assets, Ups Financial Strength, Stock Up

Post Holdings (POST) to Shut Lancaster Unit to Optimize Network
TRML

Zacks

2 years ago

Post Holdings (POST) to Shut Lancaster Unit to Optimize Network

With the Holiday Season Fast Approaching, Paysafe Research Outlines How Online Merchants Can Grow Sales
TRML

Business Wire

2 years ago

With the Holiday Season Fast Approaching, Paysafe Research Outlines How Online Merchants Can Grow Sales

Varex Imaging Corporation (NASDAQ:VREX) Q4 2023 Earnings Call Transcript
TRML

Insider Monkey

2 years ago

Varex Imaging Corporation (NASDAQ:VREX) Q4 2023 Earnings Call Transcript

Immatics Announces Third Quarter 2023 Financial Results and Business Update
TRML

GlobeNewswire

2 years ago

Immatics Announces Third Quarter 2023 Financial Results and Business Update

TRML

Business Wire

2 years ago

FCPT Announces Fourth Quarter 2023 Dividend

Share on Social Networks: